The third quarter financial results of Arbutus Biopharma Corporation (NASDAQ: ABUS) will be unveiled on Wednesday 6th November 2024. This eagerly awaited announcement is scheduled to occur before market open.
Financial analysts on Wall Street are predicting that the organization is about to reveal an estimated $0.09 loss per share for the quarter. Additionally, the company is projected to announce a total revenue of $1.86 million for this period.
When examining the earnings report from the corresponding quarter of the previous year, it is evident that the company showcased per-share loss of $0.12. This numbers can be credited to the company's total revenue, which amounted to an impressive $4.66 million during the same quarter.
The company's yearly performance has been analyzed by Wall Street analysts, who have projected a total revenue of $7.09 million. Additionally, they are expecting the company to achieve a per share loss of $0.38 for the fiscal year 2024.
The business has scheduled a conference call on 6th November 2024 at 08:45 AM eastern time to discuss Q3 financial results.
Friday's trading saw Arbutus Biopharma Corporation (ABUS) shares hit a low of $3.80 and a high of $3.99, with a day volume of 554.20 thousand shares. The stock closed the regular trading session at $3.96, indicating 2.86 percent gain.
